ResMed (RMD) Tops Q3 EPS by 5c
Tweet
Share
E-mail
Get Alerts RMD Hot Sheet
Price: $198.50 -2.63%
EPS Growth %: +13.3%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
CCEL, MHGU, PLG, More
EPS Growth %: +13.3%
Financial Fact:
Research and development: 34.45M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
ResMed (NYSE: RMD) reported Q3 EPS of $2.86, $0.05 better than the analyst estimate of $2.81. Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.42 billion.
For earnings history and earnings-related data on ResMed (RMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Starts Arrowhead Pharma (ARWR) at Buy
- PBF Energy (PBF) PT Raised to $57 at Mizuho
- Glencore Canada converts US$25M Osisko Metals debenture into shares
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
